Logan Gilland says he "loves the stock" but has "trimmed" recently as the company faces its 2Q earnings report. He adds that the company is "pre-revenue" and its small modular nuclear technology is still in development, but says the potential upside makes it an "unbelievable name." Logan says he'll be paying attention to the earnings call and guidance ranges the company provides, especially for its timeline on commercial production.